Stronger Sell Today FATE ranks #4772 as SELL CANDIDATE. Weaker Sell
Today FATE ranks #4772 as SELL CANDIDATE.

FATE stock Fate Therapeutics

FATE stock
Fate Therapeutics

23 January 2019
Change -2.62%
Chart period: 2018-10-24 - 2019-01-23
VOLUME
Sell
TREND
Buy

MV LONG
Sell

MV SHORT
Sell

PIVOT
Sell

MACD
Buy
Request Prediction
Predict

Fate Therapeutics Stock Analysis

Technical stock analysis for 23 January 2019

Sell candidate since 2019-01-22 Loss -2.62%
Shorts n/a
Cash n/a
Loans n/a
Beta 2.08
ROA -43.10

Fate Therapeutics fell by -2.62% in the last day from $14.86 to $14.47 and has now fallen 5 days in a row. The price has fallen in 7 of the last 10 days and is down by -15.73% for this period. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -46 364 shares and in total 665 426 shares bought and sold for approximately $9.63 million.

Close price at the end of the last trading day (Wednesday, 23rd Jan 2019) of the FATE stock was $14.47. This is 2.62% less than the trading day before Tuesday, 22nd Jan 2019.

During day the stock fluctuated 8.45% from a day low at $14.20 to a day high of $15.40.

30 day high of the FATE stock price was $17.84 and low was $11.07.
90 day high was $17.98 and low was $11.00.
52 week high for the Fate Therapeutics - $17.98 and low - $6.76.

Trend

Fate Therapeutics lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 18.22% during the next 3 months and, with 90% probability hold a price between $14.72 and $21.87 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

There are few to none technical positive signals at the moment. Fate Therapeutics holds sales signals from both short- and long-term moving averages. On corrections up there will be some resistance from the lines at $15.92 and $15.10. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Thursday January 10, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 56 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

On the downside, the stock finds support just below today's level from accumulated volume at $13.53 and $12.45.

There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Fate Therapeutics finds support just below today's level at $13.53. If this is broken, then the next support from accumulated volume will be at $12.45 and $11.50.

Support: $13.53 Price: $14.47 Resistance: $14.75

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.20 between high and low, or 8.45%. For the last week, the stock has had a daily average volatility of 7.17%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High

Evaluation

The Fate Therapeutics stock holds several negative signals and despite the positive trend we believe Fate Therapeutics will perform weak in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Stronger Sell Today FATE ranks #4772 as SELL CANDIDATE. Weaker Sell
Today FATE ranks #4772 as SELL CANDIDATE.